You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR FERRIC MALTOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FERRIC MALTOL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01340872 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)	Completed	Iron Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC).
NCT01340872 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)	Completed	Shield Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC).
NCT01352221 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)	Completed	Iron Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD).
NCT01352221 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)	Completed	Shield Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD).
NCT02680756 ↗	Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD	Completed	Iron Therapeutics	Phase 3	2016-01-01	The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).
NCT02680756 ↗	Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD	Completed	Shield Therapeutics	Phase 3	2016-01-01	The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FERRIC MALTOL

Condition Name

Chart
Table

Condition Name for FERRIC MALTOL
Intervention	Trials
Anemia, Iron Deficiency	4
Iron-deficiency	3
Inflammatory Bowel Disease	3
Crohn's Disease	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FERRIC MALTOL
Intervention	Trials
Anemia, Iron-Deficiency	11
Anemia	7
Inflammatory Bowel Diseases	4
Intestinal Diseases	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FERRIC MALTOL

Trials by Country

Map
Table

Trials by Country for FERRIC MALTOL
Location	Trials
United States	34
Germany	4
United Kingdom	3
Netherlands	1
France	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FERRIC MALTOL
Location	Trials
Texas	3
Florida	3
Pennsylvania	2
North Carolina	2
Nevada	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FERRIC MALTOL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FERRIC MALTOL
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	7
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FERRIC MALTOL
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	3
Recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FERRIC MALTOL

Sponsor Name

Chart
Table

Sponsor Name for FERRIC MALTOL
Sponsor	Trials
Shield Therapeutics	7
Iron Therapeutics	4
Hannover Medical School	3
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FERRIC MALTOL
Sponsor	Trials
Industry	14
Other	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.